纵向[18F]FDG PET脑代谢变化作为自身免疫性脑炎预后标志物
本研究对22例自身免疫性脑炎患者基线与治疗随访期的脑[18F]FDG PET进行体素配对t检验,识别出三个代谢显著变化的感兴趣区。所有感兴趣区代谢恢复至正常程度越差与急性和治疗后更高残疾(mRS)相关;基线VOI-B1低代谢预测随访时更高CASE评分和复发,较低年龄是升级二线治疗的显著预测因素。
要点
- 基线相对高代谢的VOI-A涉及尾状核-丘脑-海马旁回、右侧杏仁核和前扣带皮层。
- 基线相对低代谢的VOI-B1和VOI-B2分别对应右侧梭状回、楔前叶和颞顶皮层。
- 所有VOI代谢恢复至正常程度越差与急性和治疗后更高mRS相关;基线VOI-B1低代谢预测随访CASE评分更高和复发。
核心结论
- 纵向[18F]FDG PET显示自身免疫性脑炎治疗后存在与临床恢复平行的区域代谢变化。
- 颞顶代谢与复发、临床严重程度和功能损害相关,提示[18F]FDG PET可作为疾病活动性的生物学追踪工具并具有预后价值。
研究设计与样本
- 纵向研究,比较22例自身免疫性脑炎患者基线(BS)与治疗随访(FU)的脑[18F]FDG PET,采用体素配对t检验。
- 显著簇定义为至少100个体素且p < 0.05,并指定为感兴趣区(VOI)。
- VOI值与主要临床结局用偏Spearman检验相关,预后意义通过回归模型评估。
主要发现
- 三个VOI在基线(BS)与随访(FU)间显示显著代谢变化。
- VOI-A在BS相对高代谢,包括尾状核-丘脑-海马旁回区域、右侧杏仁核和前扣带皮层。
- VOI-B1和VOI-B2在BS相对低代谢,分别对应右侧梭状回、楔前叶和颞顶皮层。
- 所有VOI代谢恢复至正常程度越差与急性和治疗后更高残疾(mRS)相关。
- 基线VOI-B1较低代谢预测FU时更高CASE评分和复发,较低年龄是升级二线治疗的显著预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Recent advancements in autoimmune encephalitis (AE) have enhanced diagnosis and management, but predicting long-term outcomes remains challenging. This study aims to evaluate longitudinal changes in brain [18F]FDG PET patterns in AE patients to identify specific regional metabolic variations and predict clinical outcomes. METHODS: This longitudinal study compared brain [18F]FDG PET scans of 22 AE patients at baseline (BS) and after treatment follow-up (FU) using voxel-wise paired t-tests. Significant clusters with at least 100 voxels and p < 0.05 were identified and designated as volumes of interest (VOIs). The VOI values were correlated with main clinical outcomes using partial Spearman's tests, and their prognostic significance was assessed through regression models. RESULTS: Three VOIs showed significant metabolic changes between baseline (BS) and follow-up (FU) assessments. VOI-A, which was relatively hypermetabolic at BS, included the caudate-thalamus-parahippocampal region, right amygdala, and anterior cingulate cortex. VOI-B1 and VOI-B2, relatively hypometabolic at BS, corresponded to the right fusiform gyrus, precuneus, and temporo-parietal cortex, respectively. Poorer metabolic recovery in all VOIs to normalcy correlated with greater disability (mRS) in both acute and post-therapy phases. Lower metabolism in BS VOI-B1 predicted higher Clinical Assessment Scale in Autoimmune Encephalitis (CASE) score at FU and relapses, while lower age was a significant predictor of escalation to second-line treatment. CONCLUSIONS: Longitudinal [18F]FDG PET reveals distinct regional metabolic changes paralleling clinical recovery post-treatment in AE. Temporo-parietal metabolism correlates with relapses, clinical severity, and functional impairment, highlighting [18F]FDG PET as a biological tracker of disease activity throughout AE and its prognostic value.
引用
- Cerne D, Raffa S, Benvenuto G, et al. Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis. Eur J Nucl Med Mol Imaging. 2025. PMID: 40851055. doi:10.1007/s00259-025-07526-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。